<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778254</url>
  </required_header>
  <id_info>
    <org_study_id>38/10/2018</org_study_id>
    <nct_id>NCT04778254</nct_id>
  </id_info>
  <brief_title>PEEK Versus Metallic Attachment-retained Obturators</brief_title>
  <acronym>PEEK</acronym>
  <official_title>PEEK Versus Metallic Attachment-retained Obturators Regarding Patient Satisfaction: A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients' satisfaction evaluation and radiographic evaluation of the terminal abutments of&#xD;
      attachment- retained maxillary obturators with metal framework versus milled PEEK framework&#xD;
      in the management of maxillectomy cases.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eighteen participants were randomly divided into three parallel groups (n=6). Participants of&#xD;
      PEEK group received attachment-retained obturators with milled PEEK framework, metal group&#xD;
      received an attachment-retained obturator with metallic framework and conventional group&#xD;
      received conventional clasp-retained obturators with metallic framework (Control group).&#xD;
      Evaluation included radiographic evaluation and patients' satisfaction where two scales were&#xD;
      followed in this study, including &quot;The Obturator Functioning Scale&quot; and &quot;The European&#xD;
      Organization for Research and Treatment of Cancer Head and Neck 35&quot; using one way ANOVA test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Actual">August 30, 2019</completion_date>
  <primary_completion_date type="Actual">July 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>patient satisfaction 1(change&quot; is being assessed)</measure>
    <time_frame>1 week to 6 months</time_frame>
    <description>The Obturator Functioning Scale ( minimum value is &quot;1&quot;and maximum value is &quot;5&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>patient satisfaction 2 (change&quot; is being assessed)</measure>
    <time_frame>1 week to 6 months</time_frame>
    <description>The European Organization for Research and Treatment of Cancer Head and Neck 35 ( minimum value is &quot;1&quot;and maximum value is &quot;5&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiographic evaluation (change&quot; is being assessed)</measure>
    <time_frame>base line,6 months, 9 months,12 months</time_frame>
    <description>evaluation of terminal abutment</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Maxillary Neoplasms</condition>
  <arm_group>
    <arm_group_label>conventional obturator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional group received conventional clasp-retained obturators with metallic framework (Control group).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>metallic attachment retained obturator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>metal group received an attachment-retained obturator with metallic framework</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEEk attachment retained obturator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PEEK group received attachment-retained obturators with milled PEEK framework,</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PEEK attachment retained obturator</intervention_name>
    <description>attachment retained obturator for management of hemi maxillectomy</description>
    <arm_group_label>PEEk attachment retained obturator</arm_group_label>
    <other_name>milled PEEK obturator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>metalic attachment retained obturator</intervention_name>
    <description>attachment retained obturator for management of hemi maxillectomy</description>
    <arm_group_label>metallic attachment retained obturator</arm_group_label>
    <other_name>attachment retained obturator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>conventional obturator</intervention_name>
    <description>clasp retained obturator for management of hemi maxillectomy</description>
    <arm_group_label>conventional obturator</arm_group_label>
    <other_name>clasp retained obturator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient underwent surgical removal of half of maxilla&#xD;
&#xD;
          -  participants with a sufficient number of natural teeth(class I and \or class IV&#xD;
             Aramany classification) not less than 5 teeth, mouth opening is not less than 25 mm,&#xD;
             intact soft palate,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  participants are exposed to radiotherapy or chemotherapy during last year.&#xD;
&#xD;
          -  participant with congenital defect&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed Sharaf, lecturer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beni-Suef University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mohamed Sharaf</name>
      <address>
        <city>Cairo</city>
        <zip>11625</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 22, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>February 26, 2021</last_update_submitted>
  <last_update_submitted_qc>February 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Sharaf Mohamed Yahia</investigator_full_name>
    <investigator_title>Principal Investigator,</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Maxillary Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>finished work will be published</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

